Position in BBIO
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$83,799,756
+$12,313,888 QoQ
Shares Held
1,125,131
+16.9% QoQ
Ownership
0.576%
of shares outstanding
% of Portfolio
0.66%
of 13F equity value
Holder Rank
#43
of 472 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 94%
Shared 6%
None 0%
Common Shares in BBIO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GW&K Investment Management, LLC holds $876,997,841 across 27 Biotechnology names. BBIO ranks #3 (9.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HALO |
Halozyme Therapeutics, Inc.
|
1,353,883 | $105,968,422 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
350,667 | $84,500,226 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
This page
|
1,125,131 | $83,799,756 | |
| 4 | CYTK |
Cytokinetics Inc
|
916,107 | $78,043,155 | |
| 5 | LGND |
Ligand Pharmaceuticals Inc
|
246,883 | $78,037,246 | |
| 6 | VCEL |
Vericel Corp
|
1,550,497 | $68,981,610 | |
| 7 | INSM |
INSMED Inc
|
629,760 | $67,145,010 | |
| 8 | CRNX |
Crinetics Pharmaceuticals, Inc.
|
1,731,140 | $64,779,258 |
All Filings in BBIO
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $83,799,756 | 1,125,131 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $71,485,868 | 962,643 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $47,892,071 | 626,122 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $31,072,429 | 598,237 | Shares | Sole | 2025-11-12 | |
| No filing history on record for this holder in this stock. | ||||||